SEARCH RESULTS FOR: "Tag: JNJ"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2021(27)
2020(25)
2019(26)
2018(22)
2017(25)
2016(28)
2015(22)
2014(4)
CATEGORIES
5-Minute Market Rundown(8)
Analyst Downgrades(3)
Analyst Update(8)
Analyst Upgrades(3)
Bernie's Content(1)
Best and Worst Stocks(1)
Buzz Stocks(32)
By the Numbers(1)
Early Edge(1)
Earnings Preview(5)
Editor's Pick(2)
Ezines(1)
General(13)
Intraday Option Activity(10)
Market Recap(12)
Midday Market Check(26)
Opening View(33)
Options Recommendations(1)
Podcast(1)
Quantitative Analysis(2)
Stock Market News(9)
Stocks On the Move(4)
Strategies and Concepts(1)
Technical Analysis(2)
The Week Ahead(19)
Trade Postmortem(1)
Unusual Trading Activity(1)

8/25/2021 10:23 AM
On the heels of the first Covid-19 vaccine to receive approval from the U.S. Food and Drug Administration (FDA), Johnson & Johnson (NYSE:JNJ) announced some upbeat early-stage clinical trial news. It...
7/23/2021 2:08 PM
It was a jarring start to the week for Wall Street, with stocks in a seeming freefall as a rise in global Covid-19 cases, specifically the delta variant, had many wondering if the smooth economic re...
7/21/2021 10:03 AM
Part of the blue-chip earnings deluge this morning, the shares of Johnson & Johnson (NYSE:JNJ) are down 0.5% at $167.76 at last check, despite the pharma giant reporting better-than-expected second-q...
7/15/2021 1:00 PM
Next week will be a relatively quiet one in terms of economic data, though the National Association of Home Builders' (NAHB) index is due out. Investors will also have another round of jobs and house ...
7/2/2021 3:24 PM
Wall Street crossed over into the second half of the year, as well as a new month and quarter this week, and the transition was a seamless one. All three major indexes exhibited mostly positive pri...
 
Special Offers from Schaeffer's Trading Partners